Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial

BACKGROUND: In the multi-country PROMISE 1077BF trial, the risk of low birth weight (LBW; <2500g) and preterm delivery (PTD; <37 weeks) was higher among women initiating a protease inhibitor (PI)-based antiretroviral treatment (ART) regimen than in those receiving ZDV alone. Among those assign...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Acquir Immune Defic Syndr
Main Authors: Sebikari, Dorothy, Farhad, Mona, Fenton, Terry, Owor, Maxensia, Stringer, Jeffrey S. A., Qin, Min, Chakhtoura, Nahida, Chi, Benjamin H., Saidi, Friday, Nevrekar, Neetal, Violari, Avy, Chipato, Tsungai, McIntyre, James A., Moodley, Dhayendre, Taha, Taha E., Theron, Gerhard, Fowler, Mary Glenn
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6702964/
https://ncbi.nlm.nih.gov/pubmed/31295174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002072
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados